Molecular Pharmacology, Vol 15, 49-59, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Selective Inhibitors of Ca²⁺-Binding Modulator of Phosphodiesterase Produce Vascular Relaxation and Inhibit Actin-Myosin Interaction

¹ Department of Pharmacology, School of Medicine, Mie University, Eobashi, Tsu 514, Japan

To elucidate the role of Ca²⁺-regulated activator protein (a protein modulator) of cyclic nucleotide phosphodiesterase in smooth muscle contraction, we determined the effects of various drugs that selectively inhibit a protein modulator-induced stimulation of cyclic nucleotide phosphodiesterase on contractile response of isolated rabbit aortic strip, and superprecipitation of bovine aorta smooth muscle actomyosin, considered to be an in vitro analogue of muscle contraction. Actomyosin preparation from bovine aorta smooth muscle contained approximately 200 units (2 µg) of protein modulator per mg actomyosin and superprecipitated by addition of ATP. Selective inhibitors of the stimulation of the phosphodiesterase by a protein modulator such as N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) and its derivatives, or psychotropic agents such as chlorpromazine, chlorprothixene, amitriptyline and desipramine produced relaxation of isolated aortic strips contracted by various agonists such as KCl, CaCl₂, norepinephrine, histamine, and prostaglandin F₂. The relaxation induced by these agents was not affected by treatment with adrenergic or cholinergic blocking agents such as propranolol and atropine, suggesting that such do not work through these receptors. These drugs not only reduced the extent of actomyosin superprecipitation but also prolonged the time required to attain the maximum superprecipitation, suggesting that they inhibit the superprecipitation of aorta smooth muscle actomyosin. The addition of various amounts of protein modulator prevented in dose-dependent fashion the inhibition by these compounds of actomyosin superprecipitation. The order of the potency of the drugs was much the same in assay systems such as inhibiting the stimulation of the phosphodiesterase by a protein modulator, superprecipitation of actomyosin and producing a relaxation of aortic strip. Other vasodilating drugs such as isoproterenol, sodium nitrite and fusaric acid had no effect on smooth muscle contraction process (superprecipitation of actomyosin). Papaverine, which is a potent inhibitor of cyclic nucleotide phosphodiesterase and not a selective inhibitor, served also as the control. However, even papaverine failed to inhibit the superprecipitation. Our results provide pharmacological evidence that a protein modulator participates in the regulation in smooth muscle contraction.

Note:
ACKNOWLEDGMENTS The authors wish to thank Mr. G. Inoue for his skillful technical assistance and M. Ohara for assistance with the manuscript.

This article has been cited by other articles:

				J. Feng, M. Ito, Y. Kureishi, K. Ichikawa, M. Amano, N. Isaka, K. Okawa, A. Iwamatsu, K. Kaibuchi, D. J. Hartshorne, et al. Rho-associated Kinase of Chicken Gizzard Smooth Muscle J. Biol. Chem., February 5, 1999; 274(6): 3744 - 3752. [Abstract] [Full Text] [PDF]

				M. P. Romero, A. García-pergañeda, J. M. Guerrero, and C. Osuna Membrane-bound calmodulin in Xenopus laevis oocytes as a novel binding site for melatonin FASEB J, October 1, 1998; 12(13): 1401 - 1408. [Abstract] [Full Text]

				M. A. Schumann, C. C. Leung, and T. A. Raffin Activation of NADPH-Oxidase and Its Associated Whole-cell H[IMAGE] Current in Human Neutrophils by Recombinant Human Tumor Necrosis Factor [IMAGE] and Formyl-Methionyl-Leucyl-Phenylalanine J. Biol. Chem., June 2, 1995; 270(22): 13124 - 13132. [Abstract] [Full Text] [PDF]

				K Goto, D. Laval-Martin, and L. Edmunds Jr Biochemical modeling of an autonomously oscillatory circadian clock in Euglena Science, June 14, 1985; 228(4705): 1284 - 1288. [Abstract] [PDF]